Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation

Transplant International

Volumn 21, Issue 11, 2008, Pages 1072-1080

  Hoeger, Simone ^a   Reisenbuechler, Anke ^a   Gottmann, Uwe ^a   Doyon, Fabian ^a   Braun, Claude ^b   Kaya, Ziya ^c   Seelen, Marc A ^d   Van Son, Willem J ^d   Waldherr, Ruediger ^a   Schnuelle, Peter ^a   Yard, Benito A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Centre Hospitalier Kirchberg   (Luxembourg)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Brain dead rats; Dopamine; Kidney transplantation; Renal function; Renal inflammation

Indexed keywords

CHEMOATTRACTANT; CHEMOATTRACTANT PROTEIN 1; CREATININE; CYTOKINE; DOPAMINE; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEATH; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DONOR; FISCHER 344 RAT; GRAFT RECIPIENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE; LEWIS RAT; MACROPHAGE; MALE; MONOCYTE; NEPHRECTOMY; NEPHRITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THERAPY EFFECT;

ANIMALS; BLOOD PRESSURE; BRAIN DEATH; CHEMOKINE CXCL1; DOPAMINE; GRAFT REJECTION; GRAFT SURVIVAL; INTERLEUKIN-6; KIDNEY; KIDNEY TRANSPLANTATION; MALE; NEPHRITIS; RATS; RATS, INBRED F344; RATS, INBRED LEW;

EID: 53749088853     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00725.x     Document Type: Article

References (46)

1. Pratschke J, Neuhaus P, Tullius SG. What can be learned from brain-death models? Transpl Int 2005 18 : 15.
2. van der Woude FJ. Graft immunogenicity revisited: relevance of tissue-specific immunity, brain death and donor pretreatment. Nephron 2002 91 : 181.
3. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994 12 : 991.
4. Weiss S, Kotsch K, Francuski M, et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007 7 : 1584.
5. Mangino MJ, Kosieradzki M, Gilligan B, et al. The effects of donor brain death on renal function and arachidonic acid metabolism in a large animal model of hypothermic preservation injury. Transplantation 2003 75 : 1640.
6. Compagnon P, Wang H, Lindell SL, et al. Brain death does not affect hepatic allograft function and survival after orthotopic transplantation in a canine model. Transplantation 2002 73 : 1218.
7. Huber TS, Kluger MJ, Harris SP, et al. Plasma profiles of IL-6-like and TNF-like activities in brain-dead dogs. Am J Physiol 1991 261 : R1133.
8. Skrabal CA, Thompson LO, Potapov EV, et al. Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. J Surg Res 2005 123 : 118.
9. Takada M, Nadeau KC, Hancock WW, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998 65 : 1533.
10. Schuurs TA, Morariu AM, Ottens PJ, et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006 6 : 2903.
11. Schuurs TA, Gerbens F, van der Hoeven JA, et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant 2004 4 : 1972.
12. van der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003 64 : 1874.
13. van der Hoeven JA, Ploeg RJ, Postema F, et al. Induction of organ dysfunction and activation of inflammatory markers in donor liver and kidney during hypotensive brain death. Transplant Proc 1999 31 : 1006.
14. Pratschke J, Wilhelm MJ, Kusaka M, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999 67 : 343.
15. Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000 232 : 263.
16. Pratschke J, Wilhelm MJ, Kusaka M, et al. Acute rejection of rat renal allografts is accelerated by donor brain death. Transplant Proc 1999 31 : 874.
17. Kotsch K, Francuski M, Pascher A, et al. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant 2006 6 : 477.
18. Pratschke J, Kofla G, Wilhelm MJ, et al. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001 234 : 732.
19. Schnuelle P, Berger S, de Boer J, et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001 72 : 455.
20. Schnuelle P, Lorenz D, Mueller A, et al. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 1999 56 : 738.
21. Kapper S, Beck G, Riedel S, et al. Modulation of chemokine production and expression of adhesion molecules in renal tubular epithelial and endothelial cells by catecholamines. Transplantation 2002 74 : 253.
22. Schaub M, Ploetz CJ, Gerbaulet D, et al. Effect of dopamine on inflammatory status in kidneys of brain-dead rats. Transplantation 2004 77 : 1333.
23. Hoeger S, Gottmann U, Liu Z, et al. Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation. Transpl Int 2007 20 : 790.
24. Gottmann U, Brinkkoetter PT, Hoeger S, et al. Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition. Transplantation 2007 84 : 755.
25. Gottmann U, Mueller-Falcke A, Schnuelle P, et al. Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys. Transpl Int 2007 20 : 542.
26. Liu Z, Hoeger S, Schnuelle P, et al. Donor dopamine pretreatment inhibits tubulitis in renal allografts subjected to prolonged cold preservation. Transplantation 2007 83 : 297.
27. Solez K, Benediktsson H, Cavallo T, et al. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996 28 : 441.
28. Azevedo F, Alperovich G, Moreso F, et al. Glomerular size in early protocol biopsies is associated with graft outcome. Am J Transplant 2005 5 : 2877.
29. Weibel E. Stereological Methods: Practical Methods for Biological Morphometry, Vol. 1. London, UK : Academic Press, 1979 : 40 45.
30. Tullius SG, Heemann UW, Azuma H, et al. Alloantigen-independent factors lead to signs of chronic rejection in long-term kidney isografts. Transpl Int 1994 7 (Suppl. 1 S306.
31. Jassem W, Koo DD, Cerundolo L, et al. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 2003 76 : 1599.
32. Jassem W, Koo DD, Cerundolo L, et al. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003 75 : 2001.
33. Hoeger S, Gottmann U, Liu Z, et al. Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation. Transpl Int 2007 20 : 790.
34. Jose PA, Raymond JR, Bates MD, et al. The renal dopamine receptors. J Am Soc Nephrol 1992 2 : 1265.
35. Hetzel GR, Klein B, Brause M, et al. Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transpl Int 2002 15 : 10.
36. Peeters J, Roels L, Vanrenterghem Y. Chronic renal allograft failure: clinical overview. The Leuven Collaborative Group for Transplantation. Kidney Int Suppl 1995 52 : S97.
37. Szabo A, Muller V. [Causes of late renal transplant dysfunction]. Orv Hetil 2002 143 : 2811.
38. Schnuelle P, Gottmann U, Koppel H, et al. Comparison of early renal function parameters for the prediction of 5-year graft survival after kidney transplantation. Nephrol Dial Transplant 2007 22 : 235.
39. Shivalkar B, Van Loon J, Wieland W, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993 87 : 230.
40. Avlonitis VS, Wigfield CH, Kirby JA, et al. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005 5 : 684.
41. Schnuelle P, Yard BA, Braun C, et al. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant 2004 4 : 419.
42. Gottmann U, Brinkkoetter PT, Bechtler M, et al. Effect of pre-treatment with catecholamines on cold preservation and ischemia/reperfusion-injury in rats. Kidney Int 2006 70 : 321.
43. Guttmann RD. Manipulation of allograft immunogenicity by pretreatment of cadaver donors. Urol Clin North Am 1976 3 : 475.
44. van Schilfgaarde R, Hermans P, Terpstra JL, et al. Role of mobile passenger lymphocytes in the rejection of renal and cardiac allografts in the rat. A passenger lymphocyte-mediated graft-versus-host reaction amplifies the host response. Transplantation 1980 29 : 209.
45. Beck G, Brinkkoetter P, Hanusch C, et al. Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care 2004 8 : 485.
46. Abdi R, Slakey D, Kittur D, et al. Baseline glomerular size as a predictor of function in human renal transplantation. Transplantation 1998 66 : 329.